Introduction: Uterine fibroids are the most common benign tumours, affecting most women of childbearing age. Fibroids have brought a huge public health burden to women and also brought economic losses to society. We assessed the assessment and risk factors associated with the development of female fibroids Aim: To assess the risk factors and drug therapy in patients with uterine fibroids Methodology: We assessed the patient details from January 2020- July 2020 who were admitted to the Department of obstetrics and gynaecology (OB-GYN) for our study. The data collected were symptoms, menstrual history and present menstrual status, past medical and medication history, obstetric history and present. Results: Data from 65 patients who were presented to the department of obstetrics and gynaecology with uterine fibroids. The mean age was 43__ampersandsignplusmn;7.101 years. Most women presented were with dysmenorrhea (48%) and increased Abdominal pain (86%). Anaemia (77%) was found to be a predominant comorbid condition due to the increased menstrual bleeding and passage of clots (45%). The majority of the patients present with multiple myomas and intramural (45%) and anterior position is the most common. Surgical procedures of Hysterectomy were undergone in 95%of women. Conclusions: We observed that the significant risk factors for uterine fibroid were the age factor as most women were between 30-50 years. Menstrual history of the passage of clots and dysmenorrhea were also linked. Surgical management was used in most of the patients.